State Street’s Lantern Pharma LTRN Stock Holding History

State Street’s Portfolio LTRN Stock Details LTRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$32.4K	Hold	23,652	–	–	﹤0.01%	4178
2025 Q4	$71.7K	Hold	23,652	–	–	﹤0.01%	4106
2025 Q3	$103K	Hold	23,652	–	–	﹤0.01%	4050
2025 Q2	$74.7K	Hold	23,652	–	–	﹤0.01%	4028
2025 Q1	$83.7K	Hold	23,652	–	–	﹤0.01%	4004
2024 Q4	$75.5K	Hold	23,652	–	–	﹤0.01%	4048
2024 Q3	$86.8K	Hold	23,652	–	–	﹤0.01%	4003
2024 Q2	$110K	Sell	23,652 -1,400	-6%	-$8.42K	﹤0.01%	3981
2024 Q1	$220K	Sell	25,052 -2,700	-10%	-$14.4K	﹤0.01%	3854
2023 Q4	$119K	Hold	27,752	–	–	﹤0.01%	4026
2023 Q3	$94.6K	Hold	27,752	–	–	﹤0.01%	4126
2023 Q2	$157K	Hold	27,752	–	–	﹤0.01%	4080
2023 Q1	$134K	Hold	27,752	–	–	﹤0.01%	4223
2022 Q4	$168K	Hold	27,752	–	–	﹤0.01%	4178
2022 Q3	$133K	Hold	27,752	–	–	﹤0.01%	4328
2022 Q2	$158K	Hold	27,752	–	–	﹤0.01%	4312
2022 Q1	$198K	Buy	27,752 +2,185	+9%	+$14.6K	﹤0.01%	4388
2021 Q4	$204K	Hold	25,567	–	–	﹤0.01%	4341
2021 Q3	$286K	Buy	+25,567	New	+$331K	﹤0.01%	4223

Other funds holding LTRN

BCM

BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

WIM

Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return

Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street's LTRN Position: Q1 2026 in Review

State Street held its Lantern Pharma (LTRN) position steady in Q1 2026 at 23,652 shares worth $32.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4178.

State Street first reported a position in LTRN in Q3 2021 and has held it in 19 quarters since. The position peaked at $286K in Q3 2021. 33 funds tracked by Wall St. Rank hold LTRN as of Q1 2026.

State Street held 23,652 shares of Lantern Pharma worth $32.4K as of Q1 2026.
State Street left its Lantern Pharma share count unchanged in Q1 2026.
Lantern Pharma made up ﹤0.01% of State Street's portfolio in Q1 2026, its #4178 holding.
State Street first reported a position in Lantern Pharma in Q3 2021 and has held it in 19 quarters since.
State Street's Lantern Pharma position peaked at $286K in Q3 2021.
33 funds tracked by Wall St. Rank held Lantern Pharma as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.